<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

Neural Connections Blog

MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions

Posts about


Do clinical scores tell us all we need to know?

Multiple sclerosis is a disease in which the immune system attacks the myelin sheath that covers...

Monitoring pain in EAE animals experiencing paralysis

Many neurodegenerative diseases such as Multiple Sclerosis, ALS, and Rhett Syndrome involve...

Glatiramer Acetate (Copaxone® Generics) and Batch Release Testing in MS/EAE at MD Biosciences


MDB Gains OECD-GLP certification for In Vivo Glatiramer Acetate Batch Release Testing Services

Behavior tests used with the 6-OHDA model of PD, and what they tell us.

6-OHDA lesioned rats exhibit a number of motor behavioral and non-motor impairments which have...

Key features of the 6-OHDA model, their benefits and drawbacks

The 6-OHDA model has contributed significantly to our understanding of Parkinson’s Disease and...

What PD in Vivo Models Revealed About Pathogenesis & Treatment

Parkinson’s Disease (PD) is typically an adult-onset progressive neurodegenerative movement...